Potassium Chloride Patents (Class 424/679)
-
Patent number: 6814984Abstract: The present invention is directed to frozen biocidal compositions. Specifically, the biocidal compositions comprise a frozen aqueous solution of a plurality of ions selected from the group consisting of halide and oxyhalide ions. The frozen biocidal compositions are useful in preserving or extending the shelf-life of perishable articles.Type: GrantFiled: February 8, 2002Date of Patent: November 9, 2004Assignee: Clean Water International LLCInventors: David C. Rose, Lawrence J. Ventura
-
Publication number: 20040202726Abstract: A topical composition useful for reducing blood pressure having a liquid carrier containing water, potassium chloride, and a penetrant enhancer for enhancing the penetration of the potassium chloride into the skin.Type: ApplicationFiled: April 10, 2003Publication date: October 14, 2004Inventor: Samuel L. DeShay
-
Patent number: 6793935Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.Type: GrantFiled: February 25, 2002Date of Patent: September 21, 2004Assignee: KV Pharmaceutical CompanyInventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
-
Publication number: 20040176464Abstract: Herein is disclosed a liquid composition containing a specific amide group-containing guanidine derivative or/and a salt thereof (component A) and at least one (component B) selected from the group consisting of an inorganic salt, an organic acid salt, a nonionic surfactant and an ampholytic surfactant with an action to suppress the generation of the precipitate of the component A, in accordance with which can be provided a method for suppressing the generation of the precipitate of a specific amide group-containing guanidine derivative or/and a salt thereof in a liquid composition containing the derivative or/and a salt thereof, as well as such liquid composition with improved storage stability can be provided.Type: ApplicationFiled: February 5, 2004Publication date: September 9, 2004Applicant: Ajinomoto Co., Inc.Inventors: Eizo Kanatani, Ryosuke Yumioka, Kiyoshi Miyazawa, Hiroko Ikeda
-
Publication number: 20040161476Abstract: Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.Type: ApplicationFiled: February 19, 2003Publication date: August 19, 2004Inventors: Sungtack Samuel Hahn, Peter R. Riehl
-
Patent number: 6773726Abstract: A method is provided to take advantage of naturally occurring factors that influence gender selection in such a way as to create a bias to conceive a specific gender. This is accomplished by teaching a woman how to recognize the various stages of her menstrual cycle and how and when to use ovulation predictor reagent strips to accurately predict when ovulation will occur. Specific instructions are provided as to when a couple should engage in intercourse. The method for influencing the chances of conceiving a child of a selected gender includes the steps of following a selected diet; supplementing said diet with selected nutriceuticals; douching with a selected douche prior to intercourse; and selectively timing intercourse.Type: GrantFiled: May 29, 2002Date of Patent: August 10, 2004Inventors: Scott M. Sweazy, Jill A. Sweazy
-
Patent number: 6737083Abstract: A reconstituted ocean mixture comprising, sea salt, and the purified product of reverse osmosis of water. A method is provided for treating a pierced area of a person's skin comprising applying to the pierced area a reconstituted ocean water mixture of sea salt and the product of reverse osmosis of water.Type: GrantFiled: August 16, 2001Date of Patent: May 18, 2004Inventors: Edward Kolos, Jeffrey D. Newsom
-
Patent number: 6723334Abstract: This invention provides orthopedic cement compositions, containing calcium phosphate component, an anion-donating accelerator to promote rapid setting, and a calcium aluminate component. Further provided are methods for orthopedic repair, including placing the cement at said surgical site by applying low shearing force to said cement to initiate flow.Type: GrantFiled: March 1, 2001Date of Patent: April 20, 2004Assignee: Iowa State University Research Foundation, Inc.Inventors: Thomas D. McGee, Marie L. Roemhildt
-
Patent number: 6716884Abstract: A pharmaceutical composition for the administration of phloroglucinol includes phloroglucinol in combination with a buffer system capable of buffering the composition when placed in an aqueous medium to a pH between 3 and 7.Type: GrantFiled: January 22, 2002Date of Patent: April 6, 2004Assignee: Promindus (Actions Promotionnelles Dans l'Industrie et le Commerce)Inventors: Abderrahim Bennis, Jean-Jacques Serrano, Farid Bennis
-
Patent number: 6709680Abstract: The invention concerns the use of iso-osmotic saline solutions, in particular obtained from sea water, to obtain a medicine for cerumenolytic treatment.Type: GrantFiled: March 26, 2001Date of Patent: March 23, 2004Assignee: Laboratories Goemar S.A.Inventors: Jean-Claude Yvin, Isabelle Cadulal, Olivier Tabary
-
Publication number: 20040033272Abstract: The composition comprises a source of sodium, a source of potassium, a source of calcium and a source of magnesium, which consist of physiologically acceptable compounds of sodium, potassium, calcium and magnesium, soluble or dispersible in an aqueous medium, which in solution or dispersion in said aqueous medium provide ions of said elements. The composition is useful for the treatment of diseases of muscular, neuromuscular or osseous etiology, as well as in the treatment of states lacking or deficient in said elements, and in the muscular recovery of healthy persons and animals.Type: ApplicationFiled: May 20, 2003Publication date: February 19, 2004Inventor: Alfred Blasi Escude
-
Patent number: 6689393Abstract: A solution, in particular for hemodialysis or peritoneal dialysis that permits attaining a desired glucose concentration without affecting the concentrations of other components in the solution. The solution consists of at least three individual solutions that are combined and administered after heat sterilization. The first solution contains calcium ions, electrolyte salts and optionally glucose in a concentration of 0-1000 mM and is acidified to a pH of less than 4.0 with a physiologically tolerable acid. The second solution contains glucose in a concentration different from that of the first solution and the remaining components of the first solution in the same concentration. The third solution contains a buffer in the physiological range. Also provided is a method of preparing a solution according to the invention, where the desired mixing ratio of the separate solutions is automatically established by a dialysis machine or peritoneal dialysis cycler.Type: GrantFiled: March 22, 2000Date of Patent: February 10, 2004Assignee: Fresenius Medical Care DeutschlandInventor: Thomas Knerr
-
Publication number: 20040018245Abstract: Use of potassium for the production of a cardioplegic solution for the prevention of stone heart development during acute cardiac ventricular fibrillation in connection with cardiopulmonary resuscitation is described, as well as a cardioplegic solution comprising potassium and a method for the prevention of stone heart developement during acute cardiac ventricular fibrillation in connection wiht cardiopulmonary resuscitation.Type: ApplicationFiled: July 21, 2003Publication date: January 29, 2004Inventor: Stig Steen
-
Patent number: 6682762Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.Type: GrantFiled: October 9, 2001Date of Patent: January 27, 2004Assignee: Heart-O-Dixie Animal Nutrition, LLCInventor: Martin Kenneth Register
-
Patent number: 6680305Abstract: Physiologically acceptable aqueous solutions and methods for their use are provided. The subject solutions comprise: electrolytes; a dynamic buffering system and an oncotic agent; and do not comprise a conventional biological buffer. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute.Type: GrantFiled: April 20, 2000Date of Patent: January 20, 2004Assignee: BioTime, Inc.Inventors: Paul E. Segall, Hal Sternberg, Harold D. Waitz, Judith M. Segall
-
Publication number: 20040009219Abstract: The present invention provides a controlled release device for sustained or pulsatile delivery of pharmaceutically active substances for a predetermined period of time. This invention further provides such device in which sustained or pulsatile delivery is obtained by the unique blend and Inmate mixture of pharmaceutically active substances with a microbial polysaccharide and uncrosslinked linear polymer and optionally a crosslinked polymer and/or lipophillic polymer and/or saturated polyglycolyzed glyceride. The invention also provides a process for the manufacture of such devices and pharmaceutical compositions containing the same.Type: ApplicationFiled: September 15, 2003Publication date: January 15, 2004Inventors: Isa Odidi, Amina Odidi
-
Patent number: 6663902Abstract: The present invention relates to a biocidal composition, designed for the generation of chlorine dioxide, comprising at least one iodo-compound having at least one iodine atom and a source of chlorite ions. The molar ration of chlorite ions to iodine atoms is 2 or greater. The composition finds use in a variety of applications including methods of cleaning, sanitizing, deodorizing, and disinfecting various surfaces.Type: GrantFiled: September 19, 2000Date of Patent: December 16, 2003Assignee: Ecolab Inc.Inventors: Robert D. P. Hei, David Daniel McSherry, Kim R. Smith, Keith E. Olson
-
Publication number: 20030211156Abstract: A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidine, nonsteroidal anti-inflammatory drugs, alprenolol, ascorbic acid, captopril, theophylline, zidovoudine (AZT), bisphosphonates and mixtures thereof and pharmaceutically-acceptable excipients, wherein said oral dosage form is a generally oval form and film coated to facilitate rapid esophageal transit and avoid irritation in the mouth, buccal cavity, pharynx, and esophagus.Type: ApplicationFiled: March 28, 2003Publication date: November 13, 2003Applicant: The Procter & Gamble CompanyInventors: Richard John Dansereau, Petrus Jakobus Bekker
-
Publication number: 20030157194Abstract: A method for the topical treatment of skin affected with cellulite. Sodium chloride, potassium chloride, or a combination thereof, in a solid block formulation, is topically applied to the affected skin by gently gliding the solid block over the affected skin in a manner insufficient to cause abrasion and debridement of the affected skin. Preferably employed is a solid block of about 95 to about 100% by weight sodium chloride. Also preferably, the block of sodium chloride and/or potassium chloride is free of a carrier and/or other topical cellulite-treatment medicaments and/or cosmetics. The applied sodium chloride and/or potassium chloride is left on the skin.Type: ApplicationFiled: February 19, 2002Publication date: August 21, 2003Inventor: Ralph L. Bass
-
Patent number: 6607716Abstract: The invention discloses a natural treatment for ecto-parasitic infestation, particularly effective against lice be it head, body or pubic. A preferred gel composition includes a salt, a plant essence, and a pharmaceutically acceptable gelling agent. Besides gel, the composition designed for use on scalp hair may be formulated as a shampoo, a detangling spray conditioner, mousse, hair spray, or hair styling emulsion. The composition may be formulated as an ointment or lotion for topical use in areas with sparse hair. The invention also discloses a method of use of the composition, which is especially suited for treatment of the hair of infested children. The composition and method benefit from the soothing effects of aroma therapy. An additional benefit is that ecto-parasites do not develop resistance to the composition, which may be used repeatedly with no ill effects to the host.Type: GrantFiled: March 26, 2001Date of Patent: August 19, 2003Assignee: Tech Labs, Inc.Inventors: Robert Lee Smith, Steven Dale Smith, Wendy Dennis Langley, John Mark Christensen
-
Publication number: 20030133995Abstract: A chemical composition for an ingestible capsaicin neutralizer to neutralize the effect of capsaicin on the oral cavity, tongue, and esophagus when capsaicin from hot peppers is ingested by a user comprised of an effective neutralizing amount of casein protein, or the salt thereof, an alkali earth metal halide, and the balance water.Type: ApplicationFiled: January 17, 2002Publication date: July 17, 2003Inventors: David K. Mellott, Aren J. Mellott
-
Publication number: 20030133982Abstract: The present invention relates to zero-order sustained release solid dosage forms suitable for administration of a wide range of therapeutically active medicaments, especially those that are water-soluble, and to a process of making same. The solid dosage form comprises (a) a matrix core comprising ethylcellulose and the active agent and (b) a hydrophobic polymer coating encasing the entire matrix core.Type: ApplicationFiled: December 19, 2002Publication date: July 17, 2003Inventors: John M. Heimlich, Loksidh D. Ganorkar, Ernest J. Lee, Robert M. Noack, Ronald R. VerHage
-
Publication number: 20030108605Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.Type: ApplicationFiled: December 30, 2002Publication date: June 12, 2003Applicant: KV Pharmaceutical CompanyInventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
-
Publication number: 20030104071Abstract: This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with ethylcellulose. The granules may be compressed into tablets that disintegrate rapidly in an aqueous environment to provide uniform dissolution of the potassium chloride. Tablets containing about 10 to about 20 milliequivalents potassium may be formulated in accordance with the invention. Processes to produce extended release granules without using surfactants, processing aids or other coating aids are also provided by this invention. A method is further provided whereby a patient's supplemental potassium requirements are met by administering an appropriate combination of dosage units chosen from available dosage units containing different quantities of potassium.Type: ApplicationFiled: February 14, 2002Publication date: June 5, 2003Inventors: Bradley L. Christenson, Mark J. Pieloch
-
Publication number: 20030104070Abstract: This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with ethylcellulose. The granules may be compressed into tablets that disintegrate rapidly in an aqueous environment to provide uniform dissolution of the potassium chloride. Processes to produce extended release granules without using surfactants, processing aids or other coating aids are also provided by this invention.Type: ApplicationFiled: October 23, 2001Publication date: June 5, 2003Inventors: Bradley L. Christenson, Mark J. Pieloch
-
Publication number: 20030099722Abstract: Methods and compositions for providing glutamine supplementation to a human by orally administering an effective amount of N-acetyl-L-glutamine or a nutritionally acceptable salt thereof. The N-acetyl L-glutamine or a nutritionally acceptable salt thereof can be incorporated into any liquid composition that is suitable for human consumption. Examples of suitable compositions include aqueous solutions such as for use as oral rehydration solutions and liquid nutritional formulas (including enteral formulas, oral formulas, formulas for adults, formulas for children and formulas for infants). The quantity of N-acetyl-L-glutamine or nutritionally acceptable salt thereof can vary widely but typically, these compositions will contain sufficient N-acetyl-L-glutamine or a nutritionally acceptable salt thereof to provide at least 140 mg of total glutamine per kg of body weight per day.Type: ApplicationFiled: October 9, 2001Publication date: May 29, 2003Inventor: Jeffrey H. Baxter
-
Patent number: 6569444Abstract: A method of preparing a ruminant feed material with decreased nitrogen solubility, comprising mixing a liquid feed product containing a salt with a protein feedstuff. The protein feedstuff contains crude protein in an amount from 30% to 70% by weight. The liquid feed product containing a salt and the protein feedstuff are mixed under conditions sufficient to decrease the nitrogen solubility of the protein source. Also provided is a ruminant feed material with decreased nitrogen solubility.Type: GrantFiled: February 7, 2001Date of Patent: May 27, 2003Assignee: Ajinomoto U.S.A., Inc.Inventor: Paul Summer
-
Publication number: 20030077333Abstract: The present invention is directed to a zinc supplemented ORS and its use in the treatment of diarrhea.Type: ApplicationFiled: June 4, 2001Publication date: April 24, 2003Inventors: Kenneth M. Phillips, Amy L. Marchio, Paul F. Pollack
-
Publication number: 20030068359Abstract: A poultry and livestock feed additive composition containing 36 wt. % electrolytes, roughage and mineral oil to increase their dietary electrolyte balance. Addition of the electrolyte additive composition improves breeder hen performance as to egg production, body weight, and reduced mortality from heat stress. Broiler chickens on this diet result in increased processing yield, feed conversion and body weight. A method of preparing this dietary electrolyte feed for poultry and livestock is also described.Type: ApplicationFiled: October 9, 2001Publication date: April 10, 2003Inventor: Martin Kenneth Register
-
Patent number: 6468550Abstract: A method of improving the photochromishm of a composition comprising at least one photochromic compound with an ionic conductor, and the composition thereof. The composition may, in particular, be in the form of a care and/or make-up product for the skin, a suncare or self-tanning product, or a haircare product.Type: GrantFiled: August 25, 1998Date of Patent: October 22, 2002Assignee: L'Oreal, S.A.Inventor: Christophe Remy
-
Patent number: 6465517Abstract: The present invention describes a novel composition for the treatment of migraine, a common neurovascular syndrome, which can be elicited by functional and/or structural (symptomatic) disorders. This composition comprises taurine, coenzyme Q10 and additionally creatine, L-carnitine, certain vitamins and minerals, carbohydrates, proteins, fats and herbal extracts. Furthermore, the invention describes a method for the treatment of migraine.Type: GrantFiled: July 11, 2000Date of Patent: October 15, 2002Assignee: N.V. NutriciaInventor: Luutsche Van Der Zee
-
Patent number: 6451352Abstract: The invention concerns the use of iso-osmotic saline solutions in particular obtained from sea water, to obtain a medicine designed for a treatment preventing and limiting the release of chemical mediators responsible for causing inflammatory phenomena in the human respiratory tracts.Type: GrantFiled: May 24, 2001Date of Patent: September 17, 2002Assignee: Laboratoires Goemar S.A.Inventors: Jean-Claude Yvin, Olivier Tabary, Jacky Jacquot, Edith Puchelle
-
Patent number: 6413551Abstract: A termiticide which comprises at least one compound which in the presence of a termite produces a termiticidally effective amount of hydrogen sulfide.Type: GrantFiled: January 26, 2001Date of Patent: July 2, 2002Inventor: David William Holloway
-
Publication number: 20020061334Abstract: A solid preparation for dialysis for preparing a double preparation type sodium bicarbonate solid preparation for dialysis in which there is no fear that a sugar is decomposed or colored, and which can maintain stability and also is excellent in content homogeneity and a process for producing the same. The solid preparation for dialysis is a mixture of a first composition composed of core particles including sodium chloride that are coated with a coating layer containing one or more electrolytes, a second composition composed of core particles including a sugar that are covered with a coating layer containing one or more electrolytes, and an acid.Type: ApplicationFiled: September 27, 2001Publication date: May 23, 2002Inventors: Toshiya Kai, Kazuyuki Yamamoto, Kazutaka Fujiki, Makoto Sato
-
Publication number: 20020061340Abstract: Self-preserved nasal, inhalable and topical ophthalmic preparations and medications which destroy, inhibit or therapeutically significantly limit microbial growth within said preparations or medications. The nasal, inhalable, and topical ophthalmic preparations and medications are mildly buffered and maintain a stable pH at pH 3.5 or lower.Type: ApplicationFiled: September 20, 2001Publication date: May 23, 2002Inventor: Lee Shahinian
-
Patent number: 6387412Abstract: A storage stable magnesium oxychloride coated granular animal feed mineral supplement composition resistant to disintegration cause by moisture absorption and attrition, comprising granular mineral nutrients useful as animal feed supplements and magnesium oxychloride coatings amounting to between 0.5 and 10.0 percent of the weight of the granules, formed on the granules of mineral nutrients by coreaction of magnesium chloride and magnesium oxide. An additional coating of between 0.2 and 2.0 percent magnesium stearate formed on the magnesium oxychloride may be used to decrease the rate of wetting of the granular animal feed mineral supplements.Type: GrantFiled: April 14, 2000Date of Patent: May 14, 2002Assignee: Agri-Nutrients Technology Group, Inc.Inventor: William P. Moore
-
Patent number: 6361319Abstract: A method of decreasing the permeabilty of dentin by the application of an effective amount of oxalic acid potassium salt, dihydrate in an aqueous solution at a pH of about 2.0 to 4.0 to the dentin.Type: GrantFiled: December 20, 2000Date of Patent: March 26, 2002Inventor: Charles E. Cox
-
Patent number: 6338837Abstract: Compositions for inhibiting nematocyst or polar capsule discharge are provided in the form of an effective amount of antihistamine, an effective amount of antihistamine and an effective amount of at least one cation, or an effective amount of at least one cation. The compositions can be in the form of ointments or can be added to the environment surrounding the nematocysts or polar capsules. Methods of inhibiting nematocyst or polar capsule discharge using the compositions of the invention are also provided.Type: GrantFiled: October 8, 1997Date of Patent: January 15, 2002Assignee: Nidaria Technology Ltd.Inventor: Amit Lotan
-
Publication number: 20010048951Abstract: Improved methods of administering a synthetic plasma-like solution to a subject, as well as systems and kits for practicing the same, are provided by the subject invention. In the subject methods, the CO2 level of the subject, particularly the CO2 level of at least one of the blood and brain of the subject, is reduced prior to administration of the synthetic plasma-like solution. The subject methods find use in a variety of applications where synthetic plasma-like solutions are employed, including the treatment of hypovolemia, hyphemia, and surgical procedures in which at least a portion of a subject's blood is replaced with a synthetic plasma-like solution and provide for a number of improvements, including a reduced risk of acidosis/acidemia and complications associated therewith.Type: ApplicationFiled: April 13, 2001Publication date: December 6, 2001Inventor: Hal Sternberg
-
Patent number: 6322821Abstract: A composition for preventing and treating milk fever in freshening cows, and a method of administering the composition. The basic composition is a mixture of water, calcium chloride, propylene glycol, B vitamins and minerals. The calcium content is lower than conventional calcium treatments used for this purpose. The propylene glycol gives the cow an energy boost and sweetens the taste so the cow does not object to it as it does to conventional gels and liquids. The B vitamins stimulate the cow's appetite. The minerals replace minerals lost in the milk and also help the cow absorb calcium. The composition of the present invention is in a liquid form and is preferably administered using a 200-300 cc drench gun. The end of the dispensing tube of the drench gun is placed between the teeth and cheek of the cow near the receptors that stimulate the esophageal groove reflex.Type: GrantFiled: September 27, 1999Date of Patent: November 27, 2001Inventor: Jack W. Register
-
Patent number: 6309673Abstract: The present invention provides devices and methods for stabilizing bicarbonate-based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts—an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable, acidic pH ranging from about 1.0 to 3.0. Upon mixing, although some variation in the pH of the mixed bicarbonate solution exists, the inventors have discovered that with the appropriate selection of the parameters of the concentrates, the pH of the mixed solution is always within an acceptable physiological range.Type: GrantFiled: September 10, 1999Date of Patent: October 30, 2001Assignee: Baxter International Inc.Inventors: Annick Duponchelle, Dirk Faict, Patrick Balteau, Jean-Pierre Hartman, Leo Martis, Francesco Peluso
-
Patent number: 6291533Abstract: Dietary supplement compositions designed to be responsive to specific blood types, and thus most beneficial for people with specific antigenic blood types.Type: GrantFiled: December 22, 1999Date of Patent: September 18, 2001Assignee: Vitamerica, Inc.Inventor: Albert M. Fleischner
-
Patent number: 6287548Abstract: The present invention provides a composition of matter which has been demonstrated to be a very effective treatment for acne, seborrheic dermatitis and related skin diseases when applied to and contacted with affected skin areas, while avoiding the disadvantages and complications attendant to more established treatments. The composition comprises a synthetic mixture of salts which, when dissolved in a solvent such as water, is ionically composed primarily of a mixture of sodium and magnesium cations and chloride and sulfate anions, and which is preferably free of added zinc. More specifically, the salt mixture according to the present invention comprises the following range of composition in grams/kilogram of salt mixture in the ionic state, the balance being water of hydration: I.Type: GrantFiled: November 21, 1994Date of Patent: September 11, 2001Assignee: Bio.Life International AGInventor: Hans F. Biener
-
Patent number: 6235317Abstract: An additive for stimulants, useful in particular to reduce the health-damaging effects of coffee beverages, contains one or several vitamins, dandelion root extract, and, if required, one or several mineral salts. The additive characterized in that it contains anise extract and adenosine.Type: GrantFiled: June 16, 1999Date of Patent: May 22, 2001Inventors: György Pintz, Kinga Paczolay
-
Patent number: 6159505Abstract: Compositions for the treatment and prevention of migraine or stress headaches wherein there is supplied a combination of potassium, magnesium and pyridoxine optionally in association with other nutrients and/or simple analgesics.Type: GrantFiled: January 21, 1998Date of Patent: December 12, 2000Inventor: Edwina M. Piper
-
Patent number: 6149947Abstract: Higher concentrations of oak bark ash extract, i.e., greater than 20% by weight, are useful for the treatment of skin cancers. Lower concentrations of oak bark extract possess additional therapeutic properties not heretofore recognized. For example, preparations containing 40-80% oak bark extract are useful in the treatment of acute cancerous skin ulcers. In addition, synthetic mixtures containing potassium ions, zinc ions, calcium ions provide many of the same advantageous properties of oak bark extract. The inclusion of rubidium ions and sulfur is also advantageous for some applications.Type: GrantFiled: October 8, 1997Date of Patent: November 21, 2000Assignee: Greystone Medical Group, Inc.Inventors: David N.-S Hon, R. Thomas Stanley
-
Patent number: 6110504Abstract: An artificial plasma-like substance having at least one water soluble polysaccharide oncotic agent selected from the group consisting of high molecular weight hydroxyethyl starch, low molecular weight hydroxyethyl starch, dextran 40 and dextran 70, and albumin which is buffered by lactate and has a pre-administration pH of between 5 and 6.5 is disclosed. Also disclosed is an artificial plasma-like solution having at least two water soluble polysaccharide oncotic agents one of which is eliminated from the circulation slowly and the other of which is eliminated from the circulation quickly. Supplimentation of the plasma-like solution with certain ions is described. A system for administration of the plasma-like solution to a subject wherein the system comprises a first and second solution each having particular buffers is described. The plasma-like solution including cryoprotective adducts is also disclosed.Type: GrantFiled: February 17, 1998Date of Patent: August 29, 2000Assignee: Biotime, Inc.Inventors: Paul E. Segall, Harold D. Waitz, Hal Sternberg, Judith M. Segall
-
Patent number: 6066341Abstract: A composition for use in the rehydration and treatment of scours in calves. The composition includes fiber, electrolytes and three energy sources. The energy sources are sugar, medium chain triglycerides and glycine, present in a combined amount of about 14 percent by weight.Type: GrantFiled: March 15, 1999Date of Patent: May 23, 2000Assignee: Farnam Companies, Inc.Inventor: Colleen G. Wilson
-
Patent number: 6020007Abstract: Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.Type: GrantFiled: January 11, 1994Date of Patent: February 1, 2000Assignee: BTG International LimitedInventor: Richard L. Veech
-
Patent number: RE38604Abstract: Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.Type: GrantFiled: February 1, 2002Date of Patent: September 28, 2004Assignee: BTG International LimitedInventor: Richard L. Veech